A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
US: FDA approval not reviewed here
The registry reports recruiting. This is trial metadata, not an assessment of treatment benefit.
Phase 4 · Enrolling participants
Planned enrollment: 200 participants
Study ages: 18 Years to 80 Years
Recruiting sites listed in: United States
No results-posting date in this record
Read trial record and resultsChecked Nov 16, 2026